Effects of amiloride in lithium induced kidney interstitial fibrosis. Effects of amiloride in lithium induced kidney interstitial fibrosis
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA741543
下载链接
链接失效反馈官方服务:
资源简介:
Purpose: The goal of this study is to understand the role of co-administred amiloride. This was derived through RNAseq of kidney cortex and determining differential genes in response to lithium, lithium+amiloride and control at 14 days, 28 days and 6 months. Methods: RNAseq of kidney cortex treated with either lithium alone, lithium+amiloride or control. Deseq2 was performed using contrast argument with Wald test to identify significant differentially expression genes at each time point individually. Result & Conclusion: Co-administration with amiloride at all time points contributed in the reduction of inflammation and fibrosis caused by lithium. Overall design: mRNA profile of rats treated with lithium compared to lithium, lithium-amiloride compared to lithium at 14 days, 28 days and 6 months time points.
研究目的:本研究旨在探究联合给药阿米洛利(amiloride)的生物学作用。本数据集通过对大鼠肾脏皮质进行RNA测序(RNAseq),分析14天、28天及6个月三个时间点下,分别经单一锂剂、锂剂+阿米洛利处理及对照组样本的差异基因表达情况。
实验方法:对经单一锂剂、锂剂+阿米洛利及对照处理的肾脏皮质样本开展RNA测序(RNAseq)。采用DESeq2工具,以对比参数结合沃尔德检验(Wald test),分别在各时间点下筛选具有显著统计学差异的表达基因。
结果与结论:在所有观测时间点中,联合使用阿米洛利均可有效减轻锂剂诱导的炎症与纤维化反应。
整体实验设计:对比14天、28天及6个月三个时间点下,锂剂处理组与对照组的mRNA表达谱,以及锂剂+阿米洛利处理组与单一锂剂处理组的mRNA表达谱。
创建时间:
2021-06-25



